Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

First Page		Document Content
Date: 2010-01-13 06:39:09 Medicine Clinical medicine Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Breast cancer Treatment of cancer Chemotherapy Metastatic breast cancer Graft versus tumor effect Cell therapy Lumpectomy		Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer Add to Reading List Source URL: www.nature.com Download Document from Source Website File Size: 153,42 KB Share Document on Facebook

	Impact of hypertension in the heart Tomáš Seeman Department of Pediatrics and Transplantation Center, University Hospital Motol, 2nd Faculty of Medicine, DocID: 1vqOe - View Document
	An Official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statemen DocID: 1v5F3 - View Document
	Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine Findings support Pluristem’s ongoing Phase I study of PLX-R18 in hematopoietic recovery following hem DocID: 1uys2 - View Document
	International Liver Transplantation Symposium FORTY YEARS IN TRANSPLANTATION « WHAT DID AND WHAT DIDN’T WE REACH » Auditoires Maisin/Lacroix - Faculty of Medicine – UCL / Avenue Mounier, 1200 Woluwe – Brussels ( DocID: 1rRtC - View Document
	Programme Overview Friday 9 September00 DocID: 1rmPf - View Document